Exscientia Business and Financial Update for the Full Year 2023
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
Exscientia to Present at Upcoming Investor Conferences in March
AI drug hunter Exscientia has fired CEO Andrew Hopkins effective immediately after the board determined he had engaged in two personal relationships with employees that were deemed “inappropriate and inconsistent” with company values.
Exscientia Initiates Study to Evaluate Functional Precision Medicine Platform
Exscientia Announces Expansion of its Current Collaboration with Sanofi
OXFORD, England--(BUSINESS WIRE)--Exscientia plc (Nasdaq: EXAI) announced today that the Company received a $2.3 million grant from Open Philanthropy, a philanthropic funder with several programs in global health and wellbeing. Under this grant, Exscientia aims to harness the activation of the host interferon response as a therapeutic approach for pandemic influenza.
Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference
Exscientia Business Update for Third Quarter 2023
Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023